Z6R-29341-26639
1 vaccination
3 coded responses
9 check-ins
3 free-text entries
1 call case
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 940 / CA
- Registered
- 2021-03-20
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-19
Dose 1 — Pfizer-BioNTech
-
2021-03-20
Registered in v-safe
-
2021-03-20
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Good · Site: Pain · DiarrheaFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-21
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
-
2021-04-02
Survey response — day 14, dose 1MedDRA: Hospitalisation, Mitral valve incompetence — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Acute mitral valve relapse/regurgitation. Visited ER on 3/27, admitted and open heart surgery on 3/30 to replace mitral valve with pig tissue. No history of heart problems, but possibly hereditary link with father.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-11
Survey response — day 21, dose 1MedDRA: Hospitalisation, Pre-existing disease — Feeling: Poor · Be unable to work, Be unable to do your normal daily activitiesFree text: I previously indicated that I had been diagnosed with mitral valve relapse. This required surgery due to its acute nature. The only thing that changed in my life leading up to my hospitalization is the Pfizer shot. This is worthy of further investigaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-19 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-02 | Unsuccessful |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): No
Release 6 — day 14, dose 1
Symptoms: Acute mitral valve relapse/regurgitation. Visited ER on 3/27, admitted and open heart surgery on 3/30 to replace mitral valve with pig tissue. No history of heart problems, but possibly hereditary link with father.
Release 7 — day 21, dose 1
Symptoms: I previously indicated that I had been diagnosed with mitral valve relapse. This required surgery due to its acute nature. The only thing that changed in my life leading up to my hospitalization is the Pfizer shot. This is worthy of further investiga cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Hospitalisation | ✓ | ✓ | ✓ |
| SD | Mitral valve incompetence | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release